We mourn the loss of ISHAS member, Mark Lauer, PhD
It is with great sadness that we report the death of our Cleveland Clinic colleague, Dr. Mark Lauer, in a tragic car accident on October 12, 2015. He was 42 years old. Mark is survived by his wife and five young children, and leaves behind numerous colleagues and friends who recognized his promise and developed great respect for his achievements. Additionally, Mark was very well known for his great caring and kindness in the Lerner Research Institute as well as in his community, where he served as a deacon for his church.
Mark’s research career encompassed the fields of cell and matrix biology, and began, when he joined the laboratory of Dr. Kevin J. McCarthy at Louisiana State University as a graduate student, after earning his BA in Chemistry at Northern Kentucky University in 1997. Following completion of his PhD, Mark joined the Cleveland Clinic to continue with postdoctoral training in the laboratories of Aimin Wang (2001) and Vincent Hascall (2003), investigating the biology and pathology of extracellular matrix, focusing on heparan sulfate and especially hyaluronan.
Through his diligence and hard work, Mark rose steadily through the ranks at the Cleveland Clinic, to Research Associate (2009), Project Staff (2012), and Staff Scientist (2014) and was most recently promoted to Assistant Staff in the Pediatric Institute in June of this year. He collaborated with BME colleagues and with lung disease researchers studying, among other things, the immune system’s response to respiratory syncytial virus, a major source of infection in pediatric patients.
Mark was Principal Investigator of an R01 grant from the National Institute of Health to investigate TSG-6, a hyaluronan-binding molecule involved in inflammation. His work focused on inflammation and lung disease, especially cystic fibrosis. In addition, Mark was a co-investigator and core leader on a major Program Project Grant, one of only six nationwide under the NIH’s “Programs of Excellence (PEG) in Glycosciences. He coauthored more than 20 articles and held two patents on a promising method to treat airway inflammation.